| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/13/2007 | WO2007103770A2 Compositions and methods for analyzing renal cancer |
| 09/13/2007 | WO2007103763A2 Methods for generating and using stem cell profiles |
| 09/13/2007 | WO2007103740A2 Immunoassays, haptens, immunogens and antibodies for anti-hiv therapeutics |
| 09/13/2007 | WO2007103706A2 Nanoparticulate probe for in vivo monitoring of tissue oxygenation |
| 09/13/2007 | WO2007103633A2 Buffers for detection of mrna separated in a microfluidic device |
| 09/13/2007 | WO2007103558A2 Hybrid energy transfer for nucleic acid detection |
| 09/13/2007 | WO2007103541A2 Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells |
| 09/13/2007 | WO2007103540A2 Combination therapy with non-selective cox inhibitors to prevent cox-related gastric injuries |
| 09/13/2007 | WO2007103522A2 Soluble monomeric ephrin a1 |
| 09/13/2007 | WO2007103374A2 Toxicity screening methods |
| 09/13/2007 | WO2007103116A2 Methods and systems for evaluating health risk factors by measurement of dna damage and dna repair |
| 09/13/2007 | WO2007102892A2 Device for monitoring polymerase chain reactions |
| 09/13/2007 | WO2007102891A2 Materials and methods for assaying for methylation of cpg islands associated with genes in the evaluation of cancer |
| 09/13/2007 | WO2007102872A2 Compositions and methods related to controlled gene expression using viral vectors |
| 09/13/2007 | WO2007102869A2 Treatment of ovarian cancer with clostridium perfringens enterotoxin |
| 09/13/2007 | WO2007102797A2 Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine |
| 09/13/2007 | WO2007102787A1 Human embryonic stem cell methods and podxl expression |
| 09/13/2007 | WO2007102736A2 Interfering in activation of an immune cell by influencing interaction of lair and collagen. |
| 09/13/2007 | WO2007102713A1 Combo optical bio-chip detector system using a voice coil motor actuator |
| 09/13/2007 | WO2007102563A1 Method for determination of the effect of thrombin receptor antagonist by determination of inflammatory marker |
| 09/13/2007 | WO2007102516A1 Double-knockout non-human model animal for rna interference |
| 09/13/2007 | WO2007102507A1 Protein phosphorylation indicator |
| 09/13/2007 | WO2007102410A1 Novel use of rage polypeptide |
| 09/13/2007 | WO2007102402A1 Method of diagnosing chronic fatigue syndrome |
| 09/13/2007 | WO2007102355A1 Gene encoding transcriptional inducer for maltase gene and maltose transporter gene and use thereof |
| 09/13/2007 | WO2007102078A1 Hole-type cell carriers that promote cell adhesion and/or viability |
| 09/13/2007 | WO2007102007A2 Diagnostic methods and reagents for detection and quantification of rhodococcus equi based on choe and vapa genes |
| 09/13/2007 | WO2007101991A1 Target for the enhancement qf cognitive function |
| 09/13/2007 | WO2007101664A2 Improved aspergillosis test in clinical samples |
| 09/13/2007 | WO2007101653A1 Method of carrying out a reaction for replicating a nucleic acid |
| 09/13/2007 | WO2007101609A1 Method for the individual staging of tumor diseases |
| 09/13/2007 | WO2007101354A1 Methods of treating, reducing and inhibiting the appearance of ageing in the skin |
| 09/13/2007 | WO2007101341A1 Xaf-1, a diagnostic marker for interferon responsiveness in multiple sclerosis |
| 09/13/2007 | WO2007101306A1 Method for diagnosing and/or predicting the development of an allergic disorder and agents for treating and/or preventing same |
| 09/13/2007 | WO2007087539A3 Snp binding site for micrornas in hla-g |
| 09/13/2007 | WO2007086997A3 Sensors |
| 09/13/2007 | WO2007086904A3 Compositions for use in identification of adenoviruses |
| 09/13/2007 | WO2007075592A9 Materials and methods for treating chronic fibrotic disease |
| 09/13/2007 | WO2007073705A3 Pharmaceutical compositions containing protein nma0939 |
| 09/13/2007 | WO2007070560A3 Method for identification and monitoring of epigenetic modifications |
| 09/13/2007 | WO2007067900A3 Biomarkers for amyotrophic lateral sclerosis |
| 09/13/2007 | WO2007064355A9 Carbon nanotube-based glucose sensor |
| 09/13/2007 | WO2007058939A3 Identification of usa300 community-associated methicillin-resistant staphylococcus aureus |
| 09/13/2007 | WO2007053719A8 Chemically cleavable 3'-o-allyl-dntp-allyl-fluorophore fluorescent nucleotide analogues and related methods |
| 09/13/2007 | WO2007044453A3 Methods and apparatus for automated spore-culturing and monitoring |
| 09/13/2007 | WO2007039290A3 Methods and nucleic acids for the analysis of gene expression associated with the prognosis of cell proliferative disorders |
| 09/13/2007 | WO2007028084A3 Method and molecular diagnostic device for detection, analysis and identification of genomic dna |
| 09/13/2007 | WO2007027963A3 Methods of screening bifunctional molecules for modulated pharmacokinetic properties |
| 09/13/2007 | WO2007026252A3 In situ hybridization detection method |
| 09/13/2007 | WO2007016367A3 Neoplastic disease-related methods, kits, systems and databases |
| 09/13/2007 | WO2007014397A3 Consecutive base single molecule sequencing |
| 09/13/2007 | WO2007014305A3 Assays for resistance to echinocandin-class drugs |
| 09/13/2007 | WO2007014174A3 Drug-resistant mutants of hepatitis c virus |
| 09/13/2007 | WO2007005222A3 Cyanine dyes and methods of use in biological applications |
| 09/13/2007 | WO2006101922A3 Medicinal compositions of salts, chelates and/or free acids of alpha hydroxyl organic acids and related processes and methods |
| 09/13/2007 | WO2006089029A3 Polyelectrolyte-coated ion-exchange particles |
| 09/13/2007 | WO2006086209A3 Genetic analysis by sequence-specific sorting |
| 09/13/2007 | WO2006074350A3 Systems and methods for rapidly changing the solution environment around sensors |
| 09/13/2007 | WO2006071255A3 Bacterial replication systems and methods |
| 09/13/2007 | WO2006071241A3 Compositions for use in identification of bacteria |
| 09/13/2007 | WO2005118834A3 Methods for identifying risk of breast cancer and treatment thereof |
| 09/13/2007 | WO2000061614A8 Uncoupling proteins |
| 09/13/2007 | US20070214517 Sequence-determined DNA fragments and corresponding polypeptides encoded thereby |
| 09/13/2007 | US20070214516 Soybean Seed And Oil Compositions And Methods of Making Same |
| 09/13/2007 | US20070214511 Transgenic Bird And Method Of Constructing The Same |
| 09/13/2007 | US20070214510 Transcription factor arntl2 gene and expression products thereof used in the diagnosis, prevention, and treatment of type 1 diabetes |
| 09/13/2007 | US20070214509 Methods and systems for identifying compounds that modulate alpha-synuclein aggregation |
| 09/13/2007 | US20070213284 Method of selecting targets for gene silencing by RNA interference |
| 09/13/2007 | US20070213274 Novel genes and markers associated with high-density lipoprotein-cholesterol (HDL-C) |
| 09/13/2007 | US20070213268 inhibiting angiogenesis in tissues expressing a endocrine gland-derived vascular endothelial growth factor(EG-VEGF) polypeptide, comprising contacting the tissue with an antagonist antibody of the EG-VEGF polypeptide or an antigen binding fragment; regulating cellular proliferation and chemotaxis |
| 09/13/2007 | US20070213256 Novel genes and proteins encoded thereby |
| 09/13/2007 | US20070213255 Novel Hyaluronan-Binding Proteins and Encoding Genes |
| 09/13/2007 | US20070212774 Thermocycler with a temperature control block driven in cycles |
| 09/13/2007 | US20070212761 Incubating sample with probe having secondary structure that changes upon binding; nuclease cleavage; releasing signal generating fragment |
| 09/13/2007 | US20070212760 osmoprotectant selected from 2-methyl-4-carboxy-5-hydroxy-3,4,5,6-tetrahydropyrimidine (THP (A)), 2-methyl-4-carboxy-3,4,5,6-tetrahydropyrimidine (THP (B)) and proline effective for lowering the melting temperature of double stranded DNA; cycled primer extension on a DNA template |
| 09/13/2007 | US20070212756 Methods for treating lentivirus infections |
| 09/13/2007 | US20070212755 Novel Sequence for Improving Expression of Nucleic Acid |
| 09/13/2007 | US20070212754 Selective detection of HCV NS2/3 autocleavage activity hence; identification of potential HCV inhibitor compounds |
| 09/13/2007 | US20070212750 Microbiological test device, test and incubation systems including it, and method using it |
| 09/13/2007 | US20070212749 Detection of microbiological growth in a sealed container using a poising agent |
| 09/13/2007 | US20070212748 Detection of microbiological growth in a sealed container using a poising agent |
| 09/13/2007 | US20070212747 Cassette containing growth medium |
| 09/13/2007 | US20070212746 Quantum dot nanoparticle-based universal neurotoxin biosensor |
| 09/13/2007 | US20070212745 Beta-glucosidase and a process for extraction thereof |
| 09/13/2007 | US20070212744 Device For Analyzing The Coagulation Or Aggregation Behavior Of Blood |
| 09/13/2007 | US20070212743 Assays for Determining Anticoagulant Cofactor Activity |
| 09/13/2007 | US20070212737 Using CD44 expression profile as diagnostic indicator of cell proliferative disorders |
| 09/13/2007 | US20070212735 Using maytansinoid conjugated monoclonal antibody to treat cell proliferative disorders |
| 09/13/2007 | US20070212734 Method for Distinguishing T(11Q23)/Mll-Positive Leukemias From t(11Q23)/Mll Negative Leukemia |
| 09/13/2007 | US20070212728 32263, a novel human biotin enzyme and uses thereof |
| 09/13/2007 | US20070212727 Microorganisms for therapy |
| 09/13/2007 | US20070212726 Incubating sample with probe having secondary structure that changes upon binding; nuclease cleavage; releasing signal generating fragment |
| 09/13/2007 | US20070212725 Incubating sample with probe having secondary structure that changes upon binding; nuclease cleavage; releasing signal generating fragment |
| 09/13/2007 | US20070212724 Methods of detecting a target nucleic acid |
| 09/13/2007 | US20070212723 Human sodium channel isoforms |
| 09/13/2007 | US20070212722 generating a signal indicative of the presence of a target nucleic acid in a sample by forming a cleavage structure through incubating a sample with a probe containing a binding moiety and having a secondary structure that changes upon binding and cleaving the cleavage structure with a nuclease |
| 09/13/2007 | US20070212721 Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor |
| 09/13/2007 | US20070212720 Non-invasive method for diagnosing fetal cells and cancer cells |
| 09/13/2007 | US20070212719 Graphical rule based modeling of biochemical networks |
| 09/13/2007 | US20070212718 Apparatus and methods for applications of genomic microarrays in screening, surveillance and diagnostics |